CPBMF65, a synthetic human uridine phosphorylase-1 inhibitor, reduces HepG2 cell proliferation through cell cycle arrest and senescence.
da Silva EFG, Lima KG, Krause GC, Haute GV, Pedrazza L, Catarina AV, Gassen RB, de Souza Basso B, Dias HB, Luft C, Garcia MCR, Costa BP, Antunes GL, Basso LA, Donadio MVF, Machado P, de Oliveira JR.
da Silva EFG, et al. Among authors: de souza basso b, de oliveira jr.
Invest New Drugs. 2020 Dec;38(6):1653-1663. doi: 10.1007/s10637-020-00941-2. Epub 2020 May 4.
Invest New Drugs. 2020.
PMID: 32367200